Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Effect of Weight-Adjusted Intermediate-Dose Versus Fixed-Dose Prophylactic Anticoagulation with Low-Molecular-weight Heparin on Venous Thromboembolism among Noncritically and Critically Ill Patients with COVID-19: the COVI-DOSE Trial, a Multicenter, Randomised, Open-Label, Phase 4 Trial

Stephane Zuily,Benjamin Lefevre,Olivier Sanchez, Ombeline Empis de Vendin,Guillaume de Ciancio,Jean-Benoit Arlet,Lina Khider,Beatrice Terriat,Helene Greigert,Celine S. Robert,Guillaume Louis,Albert Trinh-Duc,Patrick Rispal,Sandrine Accassat,Guillaume Thiery,David Montani,Reza Azarian,Nicolas Meneveau,Simon Soudet,Raphael Le Mao,Francois Maurier,Vincent Le Moing,Isabelle Quere,Cecile M. Yelnik,Nicolas Lefebvre,Martin Martinot,Maxime Delrue,Ygal Benhamou,Florence Parent,Pierre-Marie Roy,Emilie Presles,Francois Goehringer,Patrick Mismetti,Laurent Bertoletti,Patrick Rossignol,Francis Couturaud,Denis Wahl,Nathalie Thilly,Silvy Laporte

ECLINICALMEDICINE（2023）

Cited 8|Views44
Key words
COVID-19,Venous thromboembolism,Heparin,Anticoagulation
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined